BIEL EMPLOYING, IMPROVING AND EXPANDING THE NETFLIX

New Post Public Reply Private Reply Replies (0) Message Board
Bielionaire
320
BIEL EMPLOYING, IMPROVING AND EXPANDING THE NETFLIX BUSINESS MODEL!
Netflix has increased over 325,000%, from .35 (on 10/9/02) to about $1,150 today!
1) Product price is about the same and Actipatch lasts as long as a monthly Netflix subscription (much longer when the on/off switch is utilized).
2) Actipatch/RecoveryRX has much larger market potential. While both are available to virtually every human on the planet, RecoveryRX Veterinary is also available to their pets! Also, the high margin RecoveryRX is available by prescription, and the "wellness market" is available for the aches and pains not covered by FDA clearances (menstrual, migraine, restless leg, depression, etc. - just attach to the vagus nerve!).
3) BIEL's product profit margins are much higher as their operating costs are virtually nothing compared to Netflix (no movie studios and actors required to constantly put out new content).
1

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

8x8, Inc. Achieves Earnings Beat with Strong Future Guidance

Updated Category News Views 91

8x8, Inc. Reports Strong Earnings Amid Growth Initiatives 8x8, Inc. (NASDAQ: EGHT), the prominent cloud communications provider, has experienced a notable uptick of 2% in its share value during after-hours trading following the release of their latest quarterly earnings. The company reported second quarter results that exceeded market expectations, providing a boost in...

Continue Reading
Investors Can Take Action in Indivior PLC Fraud Case Today

Updated Category News Views 73

Investors Encouraged to Join Indivior PLC Securities Fraud Lawsuit The Schall Law Firm, a well-known litigation firm dedicated to protecting shareholders' rights, is reaching out to investors about an important class action lawsuit against Indivior PLC (NASDAQ: INDV). This case concerns potential breaches of the Securities Exchange Act of 1934 and Rule 10b-5 as...

Continue Reading
McDermott Expands Board with New Strategic Leaders

Updated Category News Views 286

McDermott Strengthens Leadership with New Board Appointments McDermott International, Ltd has made a significant strategic move by announcing the addition of two accomplished professionals, Michael Martino and Farhad Nanji, to its Board of Directors. This change is aimed at bolstering the company’s leadership as it navigates the complex landscapes of the energy...

Continue Reading
United Therapeutics Achieves Record Stock Price of $366.23

Updated Category News Views 52

United Therapeutics Reaches New Heights in Stock Value United Therapeutics Corporation (NASDAQ: UTHR) has achieved a remarkable milestone by reaching an all-time high of $366.23. This significant increase signifies a robust period of growth for the biotech company, which has seen its stock jump by an impressive 54.22% over the past year. The surge is largely attributed to...

Continue Reading
DoorDash Surges to New Heights as Growth Strategies Flourish

Updated Category News Views 303

DoorDash Reaches New Stock Heights DoorDash (NASDAQ: DASH) has experienced a remarkable surge, with its stock recently hitting a 52-week high of $181.78. This leap signifies not only a thriving business model but also a considerable increase in investor confidence in the food delivery service. With a market cap of $75.3 billion, DoorDash has shown impressive growth with a...

Continue Reading